Deprenyl is an older trade/chemical name for selegiline, the selective MAO-B inhibitor used in Parkinson's disease described elsewhere in this catalogue. Simson Pharma's Deprenyl reference standard supports manufacturers requiring this historic nomenclature designation for legacy formulation documentation.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Deprenyl Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.